Date: 2017-09-07
Type of information: Collaboration agreement
Compound: needle-to-needle supply chain management platform
Company: Cell Therapy Catapult (UK) TrakCel (UK)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details:
- • On September 7, 2017, the Cell and Gene Therapy Catapult announced a partnership agreement with TrakCel to incorporate its needle-to-needle supply chain management platform into the CGT Catapult’s large-scale cell and gene therapy manufacturing centre. The 7,200 m2 manufacturing centre provides a state of the art GMP facility and support infrastructure to enable collaborators to carry out the large scale manufacture of cell and gene therapies as they progress towards commercial supply.
- This partnership will allow CGT Catapult collaborators to plug into an established software solution that will be able to track cell therapies across the whole supply chain, completely integrated within its validated systems at the manufacturing centre and associated cryo-storage and logistics facilities.
- The TrakCel technology will link, in addition to the manufacturing centre, with Thermo Fisher Scientific’s new Fisher Bioservices CryoHub(SM), being built adjacent to the manufacturing centre warehouse. The Cryohub will provide services for distribution of patient sample collection sets, cGMP cryo-storage of cell and gene therapies and also cryo-logistics for supply of these therapies throughout the UK and beyond, with Europe’s busiest airport (Heathrow) just an hour away.
- Finally, the TrakCel technology will help further establish the Stevenage Bioscience Catalyst, where these services are located, as an emerging cell and gene therapy cluster not just for the UK but globally by offering another world first in life sciences innovation.
- CGT Catapult specifically selected TrakCel as it has an established product installed and validated at sponsors, clinical sites, CMOs and logistic partners across North America and Europe. To minimise risks to product quality and patient safety it is essential that the supply chain is tracked and controlled both before and after the manufacturing process. The TrakCel platform has been proven to deliver this.
Financial terms:
Latest news:
Is general: Yes
